The addition of tiotropium significantly increased the time to the first severe asthma exacerbation and provided modest sustained bronchodilation compared to placebo.
TORONTO | Research published in the Journal of Experimental Medicine may provide a new avenue for the treatment of Acute Myeloid Leukemia (AML) and a solution to the high rate of disease relapse experienced by patients.